CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Best Practice +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03374995
NCT03374995N/ACompleted
CompareCT.gov

Pilot Study: KeraStat Cream for Radiation Dermatitis

Wake Forest University Health Sciences·interventional·Posted Dec 15, 2017·Updated Jun 11, 2024

In Brief

A clinical study evaluating Best Practice, Quality-of-Life Assessment, and 1 other intervention for Breast Carcinoma and Radiation-Induced Dermatitis. Completed, enrolled 25 participants across 1 site.

Detailed Summary

This randomized pilot clinical trial studies how well topical keratin works in treating radiation dermatitis in patients with breast cancer. Radiation dermatitis is a skin condition that is a common side effect of radiation therapy. The affected skin becomes painful, red, itchy, and blistered. Topical keratin may help to improve skin appearance and hydration in patients with breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Carcinoma, Radiation-Induced Dermatitis
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 15, 2017
Enrollment StartMar 26, 2018
Primary CompletionNov 1, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.5 years ago

Interventions

Best Practiceother

Receive standard of care

Quality-of-Life Assessmentother

Ancillary studies

Topical Keratindevice

Given topically